YZW-30679-09370
2 vaccinations
8 coded responses
18 check-ins
8 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 61-65
- ZIP prefix
- 030 / NH
- Registered
- 2021-03-27
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-26
Dose 1 — Pfizer-BioNTech
-
2021-03-27
Registered in v-safe
-
2021-03-27
Survey response — days 1–6 daily, dose 1MedDRA: Tinnitus — Feeling: Good · HeadacheFree text: TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-28
Survey response — days 1–6 daily, dose 1MedDRA: Exercise tolerance decreased, Fatigue — Feeling: Good · Fatigue or tirednessFree text: Attempted my normal weekly 5K run but called it quits at 2.88mi and feeling unusually fatiqued afterwards.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-29
Survey response — days 1–6 daily, dose 1MedDRA: Tinnitus — Feeling: GoodFree text: Slight tinnitus on-and-off throughout the day. Not as pronounced however as two days ago.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-30
Survey response — days 1–6 daily, dose 1MedDRA: Tension, Tinnitus — Feeling: GoodFree text: Sense of pending headache that never arrives (tension); persistent mild tinnitus.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-31
- 2021-04-01
-
2021-04-02
Survey response — day 7, dose 1MedDRA: Tinnitus — Feeling: GoodFree text: Persistent TinnitusMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-12
- 2021-04-18
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-30
Survey response — day 7, dose 2MedDRA: Tinnitus — Feeling: GoodFree text: Persistent tinnitus every day since getting the 1st dose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-07
Survey response — day 14, dose 2MedDRA: Tinnitus — Feeling: GoodFree text: Not new but the tinnitus I started experiencing with the first shot, and have experienced almost continuously since the second, still persists.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-23
- 2021-10-22
-
2022-04-25
Survey response — 12 months, dose 2MedDRA: Exposure to SARS-CoV-2, Headache, Myalgia, Oropharyngeal pain, Quarantine, SARS-CoV-2 test negative — Feeling: Good · Be unable to do your normal daily activitiesFree text: Exp COVID symptoms in Jan-headache,muscle aches, sore throat. Was exposed preceding wk. Tested neg on Binax and iHealth rapid antigen tests. Spouse tested+ w/both. Isolated at home. Both of us recovered after 2 wks.MedDRA releases: 2024-11 · check-in free text available
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-26 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Tinnitus
Systemic reaction (other): Attempted my normal weekly 5K run but called it quits at 2.88mi and feeling unusually fatiqued afterwards.
Systemic reaction (other): Slight tinnitus on-and-off throughout the day. Not as pronounced however as two days ago.
Systemic reaction (other): Sense of pending headache that never arrives (tension); persistent mild tinnitus.
Release 6 — day 7, dose 1
Systemic reaction (other): Persistent Tinnitus
Release 8 — day 7, dose 2
Systemic reaction (other): Persistent tinnitus every day since getting the 1st dose.
Release 8 — day 14, dose 2
Symptoms: Not new but the tinnitus I started experiencing with the first shot, and have experienced almost continuously since the second, still persists.
Release 11 — 12 months, dose 2
Symptoms: Exp COVID symptoms in Jan-headache,muscle aches, sore throat. Was exposed preceding wk. Tested neg on Binax and iHealth rapid antigen tests. Spouse tested+ w/both. Isolated at home. Both of us recovered after 2 wks.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Myalgia | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Quarantine | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Tinnitus | ✓ | ✓ | ✓ |
| SRO | Exercise tolerance decreased | ✓ | ✓ | ✓ |
| SRO | Fatigue | ✓ | ✓ | ✓ |
| SRO | Tension | ✓ | ✓ | ✓ |
| SRO | Tinnitus | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release